124 related articles for article (PubMed ID: 7615049)
1. Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features.
Billström R; Johansson H; Johansson B; Mitelman F
Eur J Haematol; 1995 Jul; 55(1):42-8. PubMed ID: 7615049
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
3. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
[TBL] [Abstract][Full Text] [Related]
4. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis.
Ohyashiki K; Sasao I; Ohyashiki JH; Murakami T; Iwabuchi A; Tauchi T; Saito M; Nakazawa S; Serizawa H; Ebihara Y
Cancer; 1991 Jul; 68(1):178-83. PubMed ID: 2049740
[TBL] [Abstract][Full Text] [Related]
6. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
[TBL] [Abstract][Full Text] [Related]
7. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries.
Chen B; Zhao WL; Jin J; Xue YQ; Cheng X; Chen XT; Cui J; Chen ZM; Cao Q; Yang G; Yao Y; Xia HL; Tong JH; Li JM; Chen J; Xiong SM; Shen ZX; Waxman S; Chen Z; Chen SJ
Leukemia; 2005 May; 19(5):767-75. PubMed ID: 15759035
[TBL] [Abstract][Full Text] [Related]
8. Chromosome study of 85 patients with myelodysplastic syndrome.
Musilova J; Michalova K
Cancer Genet Cytogenet; 1988 Jul; 33(1):39-50. PubMed ID: 3164239
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis in a cohort of 102 patients with myelodysplastic syndrome characterized by erythroid hyperplasia].
Yu Y; Sun AN; Chen SN; Wang QR; Zhang TT; Wu DP
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):29-33. PubMed ID: 28056320
[No Abstract] [Full Text] [Related]
11. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic abnormalities in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome].
Song LX; Guo J; He Q; Xu F; Yang LP; Li X; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):372-8. PubMed ID: 21518491
[TBL] [Abstract][Full Text] [Related]
13. Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication.
Watad A; Kacar M; Bragazzi NL; Zhou Q; Jassam M; Taylor J; Roman E; Smith A; Jones RA; Amital H; Cargo C; McGonagle D; Savic S
Front Immunol; 2021; 12():610019. PubMed ID: 33679746
[No Abstract] [Full Text] [Related]
14. [Cytogenetic study of 93 myelodysplastic syndromes].
Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
[TBL] [Abstract][Full Text] [Related]
15. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
[TBL] [Abstract][Full Text] [Related]
17. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
Michalova K; Musilova J; Zemanova Z
Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome.
Wang H; Wang XQ; Xu XP; Lin GW
Cancer Genet Cytogenet; 2010 Jan; 196(2):159-66. PubMed ID: 20082852
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features.
Wilson CS; Traweek ST; Slovak ML; Niland JC; Forman SJ; Brynes RK
Am J Clin Pathol; 1997 Oct; 108(4):369-77. PubMed ID: 9322588
[TBL] [Abstract][Full Text] [Related]
20. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
